Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Valsartan. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN115197096A reveals a high-yield catalytic method for valsartan intermediates, eliminating dimer impurities and enabling cost-effective pharmaceutical manufacturing.
Discover the novel synthesis of Valsartan via Patent CN100522953C. This route eliminates toxic tin azides, ensuring high optical purity and cost-effective manufacturing for global supply chains.
Novel patent CN115197096B offers high-yield valsartan intermediate synthesis. Reduces dimer impurities, ensures supply chain stability for pharmaceutical manufacturing.